PDCD1 and neoplasm: Recently, Wang et al. supposed that anti-angiogenesis therapy may defeat the innate resistance to PD-1/PD-L1 blockade in vascular endothelial growth factor A (VEGF-A)-overexpressed mice tumor models [249].